MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajem.2025.09.036

Медицинская библиотека · The American journal of emergency medicine · 2025

Efficacy of HFNC + NIV as initial oxygen therapy in acute respiratory failure: Meta-analysis.

Wang Weizhong, Zhang Pan, Xu Ting, Guo Haiying, Liu Weidong, Li Shunfa, Zhou Yaoying

СтатьяМетаанализСистематический обзорПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Combining non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC) may offer complementary benefits in acute respiratory failure (ARF). Prior meta-analyses compared monotherapies or post-extubation combination therapy, but none specifically evaluated NIV + HFNC as the initial strategy to prevent intubation or mortality.

OBJECTIVES

To compare the efficacy of initial NIV + HFNC versus NIV or HFNC monotherapy for preventing intubation and mortality in adults with ARF.

METHODS

We systematically searched PubMed, Embase, Cochrane Library, and Web of Science (inception to May 31, 2025) for relevant RCTs. Primary outcome was intubation rate; secondary outcome was mortality. Statistical data analysis was performed using RevMan software. Risk of bias was assessed (Cochrane RoB 2).

RESULTS

Six RCTs (N = 764 participants) were included. Compared with monotherapy, combined NIV + HFNC did not significantly affect intubation rates (OR 1.08, 95 % CI 0.79-1.49; P = 0.62; I2 = 23 %) or mortality (OR 1.41, 95 % CI 0.60-3.34; P = 0.43; I2 = 62 %). Subgroup analyses by control intervention (NIV alone or HFNC alone) and trial design (single-center vs. multi-center) also showed no statistically significant differences. Notably, the largest studies exhibited contrasting trends, potentially attributable to variations in lung-protective ventilation strategies during NIV.

CONCLUSIONS

This meta-analysis found no significant benefit of initial NIV + HFNC over monotherapy in reducing intubation or mortality in ARF. Future high-quality RCTs should prioritize standardized protocols, explicit lung-protective NIV settings, and larger sample sizes, with particular emphasis on specific ARF phenotypes that may derive maximal benefit from combined therapy.

Для цитирования: Wang Weizhong, Zhang Pan, Xu Ting, Guo Haiying, Liu Weidong, Li Shunfa, Zhou Yaoying. Efficacy of HFNC + NIV as initial oxygen therapy in acute respiratory failure: Meta-analysis.. The American journal of emergency medicine. 2025. DOI: 10.1016/j.ajem.2025.09.036.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.